Inhaled Corticosteroids: Use and Abuse

$39.50 plus tax (Refund Policy)

Buy Article:

Abstract:

Inhaled beclomethasone is an effective drug in asthma and in doses of 300-800 g/day is quite safe. Suppression of the adrenals is not a clinically important problem. New developments in delivery systems, like tube spacers will improve efficacy. Some new inhaled corticosteroids like budesonide, triamcinolone, and, flunisolide show potential for the future.

Document Type: Research Article

DOI: http://dx.doi.org/10.2500/108854184779063847

Affiliations: Department of Child Health, University of Missouri Health Sciences Center

Publication date: December 1, 1984

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more